Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry for v3.4.2 was added to the record history and the v3.4.1 entry was removed. This appears to be a site maintenance/update rather than a modification to study data.SummaryDifference0.1%

- Check20 days agoChange DetectedNew revision entry v3.4.1 was added to the record history, and the previous revision v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedUI updates include a glossary toggle, color-coded indicators for additions and deletions, and the revision label updated to v3.4.0; capitalization of 'No FEAR Act Data' was adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedA new system revision entry v3.3.4 was added to the page history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history adds Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check92 days agoChange DetectedA new revision entry 'Revision: v3.3.2' was added and the previous 'Revision: v3.2.0' was removed, indicating an administrative update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.